PRICE T ROWE ASSOCIATES INC /MD/
Position in NBIX — Neurocrine Biosciences Inc
CIK 80255
BALTIMORE, MD
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,926,465
-$245,613,334 QoQ
Shares Held
151,256
-91.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.24102184376157.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7589781562384301.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $1,875,467,383 across 39 Drug Manufacturers - Specialty & Generic names. NBIX ranks #11 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
65,864,104 | $889,824,044 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
405,447 | $240,421,961 | |
| 3 | ALKS |
Alkermes plc.
|
4,664,576 | $164,939,406 | |
| 4 | PRGO |
PERRIGO Co plc
|
13,376,776 | $143,666,573 | |
| 5 | ZTS |
Zoetis Inc.
|
1,018,088 | $120,348,181 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,201,490 | $76,611,655 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
919,732 | $69,761,671 | |
| 8 | LQDA |
Liquidia Corp
|
953,151 | $35,971,917 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,926,465 | 151,256 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $265,539,799 | 1,872,240 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $402,431,696 | 2,866,731 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $387,936,779 | 3,086,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $170,279,870 | 1,539,601 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $203,455,024 | 1,490,513 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $193,013,777 | 1,675,176 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $247,647,403 | 1,798,848 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $251,124,184 | 1,820,796 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $194,602,799 | 1,476,949 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $132,710,624 | 1,179,650 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $125,402,779 | 1,329,828 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $141,115,760 | 1,394,149 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $170,236,637 | 1,425,290 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $155,429,200 | 1,463,414 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $385,658,856 | 3,956,287 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $402,072,187 | 4,288,770 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $371,310,964 | 4,359,645 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $428,169,574 | 4,464,285 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $489,447,485 | 5,029,259 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $561,459,162 | 5,773,359 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $601,145,320 | 6,271,730 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $617,514,326 | 6,421,738 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $814,910,346 | 6,679,593 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $568,700,230 | 6,570,771 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||